BUN and/or Creatinine Increased: Intrarenal Cause
Congenital kidney anomalies
Diseases of the kidney associated with a cystic mass
Diseases of the kidney associated with a solid mass
Diseases without a mass primarily manifested as glomerular defects
Diseases without a mass in which there is primarily tubular or interstitial (tubulointerstitial) disease
Suggested Additional Lab Testing
For diseases associated with no mass that are glomerular or tubular, urinalysis is informative.
Glomerular disease is suggested by a high amount of urinary protein (including albumin) and red blood cell (RBC) casts with or without loose RBCs.
Tubular disease is suggested by a moderate degree of urinary protein that is primarily not albumin or other relatively high-molecular-weight proteins.
Granular or white blood cell (WBC) casts or loose WBCs in the urine are often associated with infection.
Because tubular dysfunction can be caused by infections and exposure to drugs, tests for infectious diseases and drug levels can be important.
Renal stones of different composition and multiple myeloma may produce tubular disease.
Tests for renal stones and multiple myeloma involve urinalysis and blood testing.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
- Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer